Malin S Nilsson

7PUBLICATIONS
23CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2025
Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.

Malin S Nilsson, Anna Martner, Lovisa Wennström

|Mar 07, 2025
Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Hana Komic, Tessa Schmachtel, Catia Simoes

|Dec 24, 2024
Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia.

Malin S Nilsson, Anna Martner, Lovisa Wennström

|Feb 01, 2020
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.

Junko Johansson, Roberta Kiffin, Ebru Aydin

|Dec 20, 2019
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.

Malin S Nilsson, Alexander Hallner, Mats Brune

|Jun 27, 2019
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.

Malin S Nilsson, Alexander Hallner, Mats Brune

Pageof 2

Frequent Collaborators

6 joint publications

Anna Martner

4 joint publications

Kristoffer Hellstrand

4 joint publications

Fredrik B Thorén

2 joint publications

Roberta Kiffin